1. Home
  2. PROF vs RNAC Comparison

PROF vs RNAC Comparison

Compare PROF & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.80

Market Cap

263.8M

Sector

Health Care

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$10.22

Market Cap

238.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROF
RNAC
Founded
N/A
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
263.8M
238.9M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
PROF
RNAC
Price
$6.80
$10.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$34.00
AVG Volume (30 Days)
139.4K
120.1K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
25.89
N/A
EPS
N/A
N/A
Revenue
$16,098,000.00
$2,797,000.00
Revenue This Year
$92.40
N/A
Revenue Next Year
$64.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
50.73
N/A
52 Week Low
$3.92
$5.60
52 Week High
$8.95
$11.39

Technical Indicators

Market Signals
Indicator
PROF
RNAC
Relative Strength Index (RSI) 44.69 68.94
Support Level $6.24 $5.88
Resistance Level $7.03 $10.98
Average True Range (ATR) 0.45 0.56
MACD -0.09 0.23
Stochastic Oscillator 14.57 77.42

Price Performance

Historical Comparison
PROF
RNAC

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: